Using a new technology developed at MIT, diagnosing lung cancer could become as easy as inhaling nanoparticle sensors and then taking a urine test that reveals whether a tumor is present.
European court rules Teva, Cephalon must pay $60M fine for reverse payment scheme after failed appeal
Teva and its subsidiary Cephalon’s hopes that a European court would dismiss or reduce more than $60 million in fines have been dashed after the
October 20, 2023